Data and Documentation
Open Data Policy
FAQ
EN
DE
FR
Suchbegriff
Advanced search
Project
Back to overview
Cell replacement therapy in mouse models with an inherited degeneration of motoneurons
English title
Thérapie par remplacement cellulaire chez des modèles de souris avec une dégénérescence héréditaire des motoneurones
Applicant
Kato Ann
Number
101098
Funding scheme
NRP 46 Implants and Transplants
Research institution
Dépt des Neurosciences Fondamentales Faculté de Médecine Université de Genève
Institution of higher education
University of Geneva - GE
Main discipline
Biomedical Engineering
Start/End
01.02.2003 - 31.07.2005
Approved amount
90'914.00
Show all
Lay Summary (English)
Lead
Lay summary
Generate BR-Tags in Abstracts Cell Replacement Therapy in Mouse Models with an Inherited Degeneration of MotorneuronsBackground/ProblemThe human CNS has a limited capacity to undergo regeneration and repair; therefore the discovery of stem cells which can re-populate regions of the degenerating brain and spinal cord has incited great interest. ObjectiveThe goal of our work is to examine mechanisms for replacing motoneurons in the context of human diseases in which these neurons specifically degenerate (amyotrophic lateral sclerosis and spinal muscular atrophy). ApproachWe are proposing a series of experiments to examine the capability of three different stem cell lines to replace degenerated motoneurons. For these studies, we plan to inject stem cells into two mouse mutants (pmn/progressive motor neuronopathy and wobbler) that have an inherited degeneration of motoneurons in the spinal cord. Due to the presence of a reporter gene (lacZ and GFP), it will be possible to examine the survival and migration of the grafted cells at different times following transplantation. One of the fundamental questions we plan to address concerns the hypothesis that the degenerated zone may release "factors" or "signals" that would guide the stem cells to re-populate this region. In our work, we plan to determine whether the grafted stem cells will migrate into a zone of the spinal cord of the mutant mice in which degeneration has occurred. These experiments would have important implications to suggest that degeneration may reactivate developmental mechanisms that are necessary for neuronal migration and survival. Cell Replacement Therapy in Mouse Models with an Inherited Degeneration of Motorneurons
Background/Problem
The human CNS has a limited capacity to undergo regeneration and repair; therefore the discovery of stem cells which can re-populate regions of the degenerating brain and spinal cord has incited great interest.
Objective
The goal of our work is to examine mechanisms for replacing motoneurons in the context of human diseases in which these neurons specifically degenerate (amyotrophic lateral sclerosis and spinal muscular atrophy).
Approach
We are proposing a series of experiments to examine the capability of three different stem cell lines to replace degenerated motoneurons. For these studies, we plan to inject stem cells into two mouse mutants (pmn/progressive motor neuronopathy and wobbler) that have an inherited degeneration of motoneurons in the spinal cord. Due to the presence of a reporter gene (lacZ and GFP), it will be possible to examine the survival and migration of the grafted cells at different times following transplantation. One of the fundamental questions we plan to address concerns the hypothesis that the degenerated zone may release "factors" or "signals" that would guide the stem cells to re-populate this region. In our work, we plan to determine whether the grafted stem cells will migrate into a zone of the spinal cord of the mutant mice in which degeneration has occurred. These experiments would have important implications to suggest that degeneration may reactivate developmental mechanisms that are necessary for neuronal migration and survival.
Direct link to Lay Summary
Last update: 21.02.2013
Responsible applicant and co-applicants
Name
Institute
Kato Ann
Dépt des Neurosciences Fondamentales Faculté de Médecine Université de Genève
Ferrer-Alcon Marcelino
Département de pharmacologie Centre médical universitaire
-